Amwill Health Care
Corporate Action-Board approves Dividend
Filed with BSE ·
6ix is reading this filing.
View original source (BSE India)Amwill Health Care Ltd on 6ix
Earlier from Amwill Health Care
- Disclosure Under Regulation 42 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
- Approval Of Unaudited Financial Results Of The Company For The Half Year Ended September 30, 2026, For The Financial Year 2026-27.
- Board Meeting Outcome for Board Meeting Outcome Of The Meeting Of The Board Of Directors Held On October 23Rd, 2026.
- Board Meeting Intimation for Approval And Take On Record Unaudited Financial Results Of The Company For The Half Year Ended September 30, 2026 (H1) Of Financial Year 2026-27 And Consider Declaration Of An Interim Dividend To The Equity Shareholders.
- Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Grant Of Licence/Regulatory Approval For Import Of Folicolor- Oxidative Hair Colour.
Follow Amwill Health Care into a list and get an email when it puts out news.
Follow Amwill Health Care